Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 17 | 2022 | 595 | 1.300 |
Why?
|
| Neuropsychological Tests | 14 | 2022 | 916 | 0.610 |
Why?
|
| Cognition Disorders | 8 | 2018 | 724 | 0.560 |
Why?
|
| Glucosylceramidase | 4 | 2022 | 13 | 0.470 |
Why?
|
| Gait Disorders, Neurologic | 3 | 2020 | 120 | 0.380 |
Why?
|
| Subthalamic Nucleus | 2 | 2022 | 19 | 0.380 |
Why?
|
| Deep Brain Stimulation | 2 | 2022 | 36 | 0.360 |
Why?
|
| Tourette Syndrome | 1 | 2009 | 10 | 0.300 |
Why?
|
| Accidental Falls | 2 | 2020 | 105 | 0.270 |
Why?
|
| Cognition | 4 | 2022 | 1025 | 0.240 |
Why?
|
| Dementia | 4 | 2016 | 415 | 0.230 |
Why?
|
| Male | 22 | 2022 | 12636 | 0.230 |
Why?
|
| Female | 22 | 2022 | 13117 | 0.230 |
Why?
|
| Huntington Disease | 2 | 2020 | 45 | 0.230 |
Why?
|
| Middle Aged | 18 | 2022 | 7964 | 0.230 |
Why?
|
| Quality of Life | 1 | 2009 | 564 | 0.220 |
Why?
|
| Aged | 18 | 2022 | 7638 | 0.220 |
Why?
|
| Executive Function | 4 | 2018 | 94 | 0.210 |
Why?
|
| Mutation | 4 | 2022 | 329 | 0.210 |
Why?
|
| Phonation | 1 | 2003 | 4 | 0.200 |
Why?
|
| Speech Disorders | 1 | 2003 | 10 | 0.200 |
Why?
|
| Electric Stimulation | 1 | 2003 | 46 | 0.200 |
Why?
|
| Respiration | 1 | 2003 | 27 | 0.200 |
Why?
|
| Speech | 1 | 2003 | 21 | 0.200 |
Why?
|
| Cognitive Dysfunction | 4 | 2016 | 803 | 0.190 |
Why?
|
| Severity of Illness Index | 7 | 2017 | 804 | 0.190 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2012 | 273 | 0.190 |
Why?
|
| Humans | 23 | 2022 | 23156 | 0.180 |
Why?
|
| Heterozygote | 1 | 2022 | 90 | 0.170 |
Why?
|
| Hallucinations | 2 | 2014 | 38 | 0.160 |
Why?
|
| Movement Disorders | 2 | 2013 | 57 | 0.160 |
Why?
|
| Disease Progression | 3 | 2016 | 543 | 0.140 |
Why?
|
| Ataxia | 1 | 2018 | 75 | 0.130 |
Why?
|
| Tremor | 1 | 2018 | 94 | 0.130 |
Why?
|
| Corpus Callosum | 1 | 2017 | 10 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 871 | 0.120 |
Why?
|
| Fragile X Syndrome | 1 | 2018 | 186 | 0.120 |
Why?
|
| Postural Balance | 1 | 2016 | 105 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 176 | 0.110 |
Why?
|
| Memory Disorders | 2 | 2014 | 115 | 0.110 |
Why?
|
| Nerve Net | 1 | 2014 | 34 | 0.100 |
Why?
|
| Psychotherapy, Psychodynamic | 1 | 2013 | 1 | 0.100 |
Why?
|
| Psychotherapy, Brief | 1 | 2013 | 2 | 0.100 |
Why?
|
| Somatoform Disorders | 1 | 2013 | 14 | 0.100 |
Why?
|
| Societies, Medical | 1 | 2014 | 117 | 0.100 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 128 | 0.100 |
Why?
|
| Psychometrics | 1 | 2013 | 184 | 0.100 |
Why?
|
| Entorhinal Cortex | 1 | 2012 | 17 | 0.090 |
Why?
|
| Sleep Wake Disorders | 1 | 2013 | 110 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2020 | 485 | 0.090 |
Why?
|
| Sleep | 1 | 2013 | 270 | 0.080 |
Why?
|
| Atrophy | 3 | 2017 | 65 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2017 | 3857 | 0.080 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2009 | 15 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 106 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2016 | 369 | 0.070 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 31 | 0.070 |
Why?
|
| Attention | 3 | 2014 | 101 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2016 | 775 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2009 | 569 | 0.070 |
Why?
|
| Adolescent | 2 | 2009 | 1883 | 0.060 |
Why?
|
| Adult | 5 | 2015 | 6942 | 0.060 |
Why?
|
| Psychophysiologic Disorders | 1 | 2005 | 6 | 0.060 |
Why?
|
| Psychotherapy | 1 | 2005 | 38 | 0.060 |
Why?
|
| Child | 1 | 2009 | 1160 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2020 | 2989 | 0.060 |
Why?
|
| Gait | 2 | 2020 | 384 | 0.050 |
Why?
|
| Speech Articulation Tests | 1 | 2003 | 3 | 0.050 |
Why?
|
| Acoustics | 1 | 2003 | 12 | 0.050 |
Why?
|
| Task Performance and Analysis | 1 | 2003 | 44 | 0.050 |
Why?
|
| Mental Status Schedule | 2 | 2015 | 72 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 444 | 0.040 |
Why?
|
| Memory | 2 | 2013 | 223 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2022 | 310 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2015 | 1463 | 0.040 |
Why?
|
| Walk Test | 1 | 2020 | 10 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 2020 | 162 | 0.040 |
Why?
|
| Walking Speed | 1 | 2018 | 35 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2016 | 48 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 139 | 0.030 |
Why?
|
| Depression | 2 | 2012 | 383 | 0.030 |
Why?
|
| Range of Motion, Articular | 1 | 2018 | 564 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 58 | 0.030 |
Why?
|
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 1 | 2015 | 5 | 0.030 |
Why?
|
| Space Perception | 1 | 2014 | 19 | 0.030 |
Why?
|
| Probability | 1 | 2014 | 72 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 265 | 0.030 |
Why?
|
| Language | 1 | 2014 | 57 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2013 | 64 | 0.030 |
Why?
|
| Sleep Stages | 1 | 2013 | 19 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1103 | 0.020 |
Why?
|
| Amnesia | 1 | 2012 | 19 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 86 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 215 | 0.020 |
Why?
|
| Checklist | 1 | 2011 | 33 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 125 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 269 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 437 | 0.020 |
Why?
|
| Hippocampus | 1 | 2012 | 196 | 0.020 |
Why?
|
| United States | 1 | 2015 | 1796 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 594 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 368 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2010 | 225 | 0.020 |
Why?
|
| Mass Screening | 1 | 2010 | 162 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2005 | 88 | 0.010 |
Why?
|
| Anti-Anxiety Agents | 1 | 2005 | 38 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2005 | 89 | 0.010 |
Why?
|
| Anxiety | 1 | 2005 | 143 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 1264 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 1430 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2005 | 2942 | 0.010 |
Why?
|